Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7329 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD1313 |
Approved |
0.6747 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6644 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6607 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6587 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD8836 |
Approved |
0.6529 |
Remote Similarity |
NPD8120 |
Approved |
0.6529 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6522 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.651 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6503 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6491 |
Remote Similarity |
NPD1215 |
Discontinued |
0.649 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6489 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.6484 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6478 |
Remote Similarity |
NPD4240 |
Approved |
0.6471 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.6467 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6453 |
Remote Similarity |
NPD2333 |
Discontinued |
0.6447 |
Remote Similarity |
NPD248 |
Discontinued |
0.6433 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6425 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6421 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.642 |
Remote Similarity |
NPD7111 |
Discontinued |
0.6407 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.6404 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.64 |
Remote Similarity |
NPD3799 |
Suspended |
0.6384 |
Remote Similarity |
NPD40 |
Phase 2 |
0.6384 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.6369 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6364 |
Remote Similarity |
NPD5843 |
Discontinued |
0.6359 |
Remote Similarity |
NPD3430 |
Approved |
0.6359 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6359 |
Remote Similarity |
NPD3431 |
Approved |
0.6359 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.6341 |
Remote Similarity |
NPD4568 |
Phase 2 |
0.6304 |
Remote Similarity |
NPD6761 |
Discontinued |
0.6302 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6301 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6301 |
Remote Similarity |
NPD6794 |
Approved |
0.6289 |
Remote Similarity |
NPD3695 |
Approved |
0.6289 |
Remote Similarity |
NPD3696 |
Approved |
0.6287 |
Remote Similarity |
NPD2524 |
Discontinued |
0.627 |
Remote Similarity |
NPD7722 |
Suspended |
0.6264 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6264 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6264 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6257 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.625 |
Remote Similarity |
NPD5324 |
Clinical (unspecified phase) |
0.6243 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.6236 |
Remote Similarity |
NPD3041 |
Approved |
0.6235 |
Remote Similarity |
NPD171 |
Discontinued |
0.6223 |
Remote Similarity |
NPD5462 |
Discontinued |
0.6222 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6222 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.6222 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.6215 |
Remote Similarity |
NPD7006 |
Approved |
0.6207 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6201 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.6201 |
Remote Similarity |
NPD3409 |
Phase 1 |
0.6201 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.6193 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6193 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.619 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD1257 |
Approved |
0.619 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.6186 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.6186 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.6186 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.6186 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.6183 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6183 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.618 |
Remote Similarity |
NPD2406 |
Clinical (unspecified phase) |
0.6178 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.6175 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6175 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6175 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6175 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.6162 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6141 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.614 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.6134 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6134 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6133 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.6131 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6127 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6127 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6124 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.6121 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6121 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.6118 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6118 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6103 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.6096 |
Remote Similarity |
NPD6577 |
Clinical (unspecified phase) |
0.6094 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.6093 |
Remote Similarity |
NPD306 |
Approved |
0.6091 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.6087 |
Remote Similarity |
NPD5642 |
Approved |
0.6087 |
Remote Similarity |
NPD193 |
Suspended |
0.6085 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6082 |
Remote Similarity |
NPD5012 |
Phase 2 |
0.6081 |
Remote Similarity |
NPD8831 |
Approved |
0.6081 |
Remote Similarity |
NPD8833 |
Approved |
0.6075 |
Remote Similarity |
NPD2818 |
Discontinued |
0.6074 |
Remote Similarity |
NPD174 |
Discontinued |
0.6071 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6071 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.6071 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.6057 |
Remote Similarity |
NPD3889 |
Approved |
0.6057 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6054 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.6048 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6041 |
Remote Similarity |
NPD3860 |
Discontinued |
0.604 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.6036 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6036 |
Remote Similarity |
NPD1030 |
Approved |
0.6036 |
Remote Similarity |
NPD1027 |
Approved |
0.6031 |
Remote Similarity |
NPD2364 |
Suspended |
0.6022 |
Remote Similarity |
NPD7504 |
Discontinued |
0.6012 |
Remote Similarity |
NPD185 |
Approved |
0.6011 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.601 |
Remote Similarity |
NPD4142 |
Discontinued |
0.601 |
Remote Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.6 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.6 |
Remote Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.5989 |
Remote Similarity |
NPD702 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD4716 |
Approved |
0.5989 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.5988 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD4863 |
Approved |
0.5978 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.5977 |
Remote Similarity |
NPD1288 |
Clinical (unspecified phase) |
0.5969 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.5969 |
Remote Similarity |
NPD2880 |
Discontinued |
0.5969 |
Remote Similarity |
NPD6271 |
Approved |
0.5967 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.5967 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.5966 |
Remote Similarity |
NPD7988 |
Suspended |
0.5965 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5962 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.5957 |
Remote Similarity |
NPD7709 |
Discontinued |
0.5956 |
Remote Similarity |
NPD1895 |
Discontinued |
0.5956 |
Remote Similarity |
NPD1674 |
Clinical (unspecified phase) |
0.5956 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5956 |
Remote Similarity |
NPD1675 |
Phase 1 |
0.5951 |
Remote Similarity |
NPD4854 |
Phase 3 |
0.595 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.595 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD4298 |
Clinical (unspecified phase) |
0.5946 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.5943 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5939 |
Remote Similarity |
NPD249 |
Approved |
0.5939 |
Remote Similarity |
NPD166 |
Approved |
0.5939 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.5939 |
Remote Similarity |
NPD250 |
Approved |
0.5938 |
Remote Similarity |
NPD5885 |
Approved |
0.5934 |
Remote Similarity |
NPD3432 |
Approved |
0.5932 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.593 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5928 |
Remote Similarity |
NPD1988 |
Phase 1 |
0.5926 |
Remote Similarity |
NPD7127 |
Clinical (unspecified phase) |
0.5918 |
Remote Similarity |
NPD7103 |
Approved |
0.5914 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5909 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5906 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.59 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5897 |
Remote Similarity |
NPD4924 |
Clinical (unspecified phase) |
0.5897 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5897 |
Remote Similarity |
NPD5486 |
Discontinued |
0.5896 |
Remote Similarity |
NPD2150 |
Discontinued |
0.5893 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5885 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.5882 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD4155 |
Approved |
0.5879 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5877 |
Remote Similarity |
NPD8004 |
Discontinued |
0.5875 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.5873 |
Remote Similarity |
NPD1658 |
Discontinued |
0.5871 |
Remote Similarity |
NPD7164 |
Discontinued |
0.5868 |
Remote Similarity |
NPD4864 |
Approved |
0.5868 |
Remote Similarity |
NPD195 |
Approved |
0.5868 |
Remote Similarity |
NPD186 |
Discovery |
0.5868 |
Remote Similarity |
NPD4047 |
Discontinued |
0.5864 |
Remote Similarity |
NPD4294 |
Phase 2 |
0.5864
|
Remote Similarity |
NPD5464 |
Approved |